Answer
It is licensed for selected adults with Waldenström’s macroglobulinaemia, marginal zone lymphoma, chronic lymphocytic leukaemia, mantle cell lymphoma and follicular lymphoma. Eligibility and combination treatment depend on the cancer and previous therapy.
Sources for this answer
- BRUKINSA 80 mg hard capsulesemc · SmPC Current selected SmPC · Version 8